Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.
Deficiencies in the ING4 tumor suppressor are associated with advanced stage tumors and poor patient survival in cancer. ING4 was shown to inhibit NF-kB in several cancers. As NF-kB is a key mediator of immune response, the ING4/NF-kB axis is likely to manifest in tumor-immune modulation but has not...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0304194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850092366784888832 |
|---|---|
| author | Emily Tsutsumi Anne M Macy Janine LoBello Karen T Hastings Suwon Kim |
| author_facet | Emily Tsutsumi Anne M Macy Janine LoBello Karen T Hastings Suwon Kim |
| author_sort | Emily Tsutsumi |
| collection | DOAJ |
| description | Deficiencies in the ING4 tumor suppressor are associated with advanced stage tumors and poor patient survival in cancer. ING4 was shown to inhibit NF-kB in several cancers. As NF-kB is a key mediator of immune response, the ING4/NF-kB axis is likely to manifest in tumor-immune modulation but has not been investigated. To characterize the tumor immune microenvironment associated with ING4-deficient tumors, three approaches were employed in this study: First, tissue microarrays composed of 246 primary breast tumors including 97 ING4-deficient tumors were evaluated for the presence of selective immune markers, CD68, CD4, CD8, and PD-1, using immunohistochemical staining. Second, an immune-competent mouse model of ING4-deficient breast cancer was devised utilizing CRISPR-mediated deletion of Ing4 in a Tp53 deletion-derived mammary tumor cell line; mammary tumors were evaluated for immune markers using flow cytometry. Lastly, the METABRIC gene expression dataset was evaluated for patient survival related to the immune markers associated with Ing4-deleted tumors. The results showed that CD68, CD4, CD8, or PD-1, was not significantly associated with ING4-deficient breast tumors, indicating no enrichment of macrophages, T cells, or exhausted T cell types. In mice, Ing4-deleted mammary tumors had a growth rate comparable to Ing4-intact tumors but showed increased tumor penetrance and metastasis. Immune marker analyses of Ing4-deleted tumors revealed a significant increase in tumor-associated macrophages (Gr-1loCD11b+F4/80+) and a decrease in granzyme B-positive (GzmB+) CD4+ T cells, indicating a suppressive and/or less tumoricidal immune microenvironment. The METABRIC data analyses showed that low expression of GZMB was significantly associated with poor patient survival, as was ING4-low expression, in the basal subtype of breast cancer. Patients with GZMB-low/ING4-low tumors had the worst survival outcomes (HR = 2.80, 95% CI 1.36-5.75, p = 0.0004), supportive of the idea that the GZMB-low immune environment contributes to ING4-deficient tumor progression. Collectively, the study results demonstrate that ING4-deficient tumors harbor a microenvironment that contributes to immune evasion and metastasis. |
| format | Article |
| id | doaj-art-e51079fd04424ee59031bfd8308e93f7 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e51079fd04424ee59031bfd8308e93f72025-08-20T02:42:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01197e030419410.1371/journal.pone.0304194Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.Emily TsutsumiAnne M MacyJanine LoBelloKaren T HastingsSuwon KimDeficiencies in the ING4 tumor suppressor are associated with advanced stage tumors and poor patient survival in cancer. ING4 was shown to inhibit NF-kB in several cancers. As NF-kB is a key mediator of immune response, the ING4/NF-kB axis is likely to manifest in tumor-immune modulation but has not been investigated. To characterize the tumor immune microenvironment associated with ING4-deficient tumors, three approaches were employed in this study: First, tissue microarrays composed of 246 primary breast tumors including 97 ING4-deficient tumors were evaluated for the presence of selective immune markers, CD68, CD4, CD8, and PD-1, using immunohistochemical staining. Second, an immune-competent mouse model of ING4-deficient breast cancer was devised utilizing CRISPR-mediated deletion of Ing4 in a Tp53 deletion-derived mammary tumor cell line; mammary tumors were evaluated for immune markers using flow cytometry. Lastly, the METABRIC gene expression dataset was evaluated for patient survival related to the immune markers associated with Ing4-deleted tumors. The results showed that CD68, CD4, CD8, or PD-1, was not significantly associated with ING4-deficient breast tumors, indicating no enrichment of macrophages, T cells, or exhausted T cell types. In mice, Ing4-deleted mammary tumors had a growth rate comparable to Ing4-intact tumors but showed increased tumor penetrance and metastasis. Immune marker analyses of Ing4-deleted tumors revealed a significant increase in tumor-associated macrophages (Gr-1loCD11b+F4/80+) and a decrease in granzyme B-positive (GzmB+) CD4+ T cells, indicating a suppressive and/or less tumoricidal immune microenvironment. The METABRIC data analyses showed that low expression of GZMB was significantly associated with poor patient survival, as was ING4-low expression, in the basal subtype of breast cancer. Patients with GZMB-low/ING4-low tumors had the worst survival outcomes (HR = 2.80, 95% CI 1.36-5.75, p = 0.0004), supportive of the idea that the GZMB-low immune environment contributes to ING4-deficient tumor progression. Collectively, the study results demonstrate that ING4-deficient tumors harbor a microenvironment that contributes to immune evasion and metastasis.https://doi.org/10.1371/journal.pone.0304194 |
| spellingShingle | Emily Tsutsumi Anne M Macy Janine LoBello Karen T Hastings Suwon Kim Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. PLoS ONE |
| title | Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. |
| title_full | Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. |
| title_fullStr | Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. |
| title_full_unstemmed | Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. |
| title_short | Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. |
| title_sort | tumor immune microenvironment permissive to metastatic progression of ing4 deficient breast cancer |
| url | https://doi.org/10.1371/journal.pone.0304194 |
| work_keys_str_mv | AT emilytsutsumi tumorimmunemicroenvironmentpermissivetometastaticprogressionofing4deficientbreastcancer AT annemmacy tumorimmunemicroenvironmentpermissivetometastaticprogressionofing4deficientbreastcancer AT janinelobello tumorimmunemicroenvironmentpermissivetometastaticprogressionofing4deficientbreastcancer AT karenthastings tumorimmunemicroenvironmentpermissivetometastaticprogressionofing4deficientbreastcancer AT suwonkim tumorimmunemicroenvironmentpermissivetometastaticprogressionofing4deficientbreastcancer |